AR and prostate carcinoma: By applying ChIPseq and RNA sequencing of the transcriptome (RNA-Seq), the authors provided the first AR cistrome in primary prostate fetal fibroblasts and CAFs [72], strengthening the biological and clinical relevance of AR-regulated changes in prostate cancer.